My Dashboard
Fin. Planning
Our Solutions
Stocks
Funds
Invest in the best stock opportunities right now and every-time.
Start Systematic Stock Investing ...in less than a minute.
BSE: 526301 | NSE: | Hospital & Healthcare Services | Small Cap
1. Is Medinova Diagnostic Services Ltd a good quality company?
Past 10 year's financial track record analysis by Moneyworks4me indicates that Medinova Diagnostic Services Ltd is a average quality company.
2. Is Medinova Diagnostic Services Ltd undervalued or overvalued?
The key valuation ratios of Medinova Diagnostic Services Ltd's currently when compared to its past seem to suggest it is in the Fair zone.
3. Is Medinova Diagnostic Services Ltd a good buy now?
The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of Medinova Diagnostic Services Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.
Value Creation ⓘValue Creation Index Colour Code Guide ⓘ |
|||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar'14 | Mar'15 | Mar'16 | Mar'17 | Mar'18 | Mar'19 | Mar'20 | Mar'21 | Mar'22 | Mar'23 | TTM | |||
| ROCE % ⓘ | -16.5% | 81.2% | 28.7% | 39% | 21.3% | 1.9% | -0% | -84.8% | -1,99,328.3% | 40.6% | - | ||
| Value Creation Index ⓘ | NA | NA | NA | NA | NA | NA | NA | -7.1 | -14238.7 | 1.9 | - | ||
Growth Parameters ⓘGrowth Parameters Colour Code Guide ⓘ |
|||||||||||||
| Sales ⓘ | 11.1 | 7.7 | 7 | 6 | 6.7 | 6.7 | 5.5 | 11.3 | 11.5 | 7.8 | 8 | ||
| YoY Gr. Rt. % | - | -30.6% | -9% | -14.1% | 11.2% | 0.9% | -18.6% | 106.2% | 1.7% | -32.6% | - | ||
| Adj EPS ⓘ | -1 | -3.7 | -1.7 | -1.7 | -1 | -0.4 | -0.3 | 2.2 | 2.1 | 0.6 | 0.6 | ||
| YoY Gr. Rt. % | - | NA | NA | NA | NA | NA | NA | NA | -4.2% | -69.7% | - | ||
| BVPS (₹) ⓘ | -3.4 | -7.2 | -8.9 | -8 | -8.2 | -7.4 | -7.7 | -5.6 | -3.5 | -2.8 | -2.8 | ||
| Adj Net Profit ⓘ | -0.9 | -3.5 | -1.6 | -1.7 | -1 | -0.4 | -0.3 | 2.2 | 2.1 | 0.6 | 1 | ||
| Cash Flow from Ops. ⓘ | 1.7 | -0.2 | 1.8 | -0.7 | 0.4 | 0.5 | 0.4 | 1.5 | 1.1 | 1.2 | - | ||
| Debt/CF from Ops. ⓘ | 0.2 | -7.7 | 2.7 | -7.3 | 13.3 | 8.6 | 10.3 | 2.2 | 5.1 | 4.9 | - | ||
CAGR ⓘCAGR Colour Code Guide ⓘ |
||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 9 Years | 5 Years | 3 Years | 1 Years | |||||||||
| Sales ⓘ | -3.9% | 3% | 12.2% | -32.6% | ||||||||
| Adj EPS ⓘ | NA | NA | NA | -69.7% | ||||||||
| BVPSⓘ | NA | NA | NA | NA | ||||||||
| Share Price | 23.8% | 9.6% | 24.4% | 17.3% | ||||||||
Key Financial Parameters ⓘPerformance Ratio Colour Code Guide ⓘ |
||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar'14 | Mar'15 | Mar'16 | Mar'17 | Mar'18 | Mar'19 | Mar'20 | Mar'21 | Mar'22 | Mar'23 | TTM | ||
| Return on Equity % ⓘ | 28.8 | 70 | 20.8 | 21 | 12.5 | 4.7 | 3.9 | -32.7 | -46 | -20 | -20 | |
| Op. Profit Mgn % ⓘ | -3.5 | -42.7 | -6.8 | -10.8 | -2.9 | 4.5 | 5.5 | 23.2 | 26.5 | 19.1 | 17.8 | |
| Net Profit Mgn % ⓘ | -8.3 | -45.3 | -22.6 | -28.6 | -15.1 | -5.4 | -5.4 | 19.1 | 18 | 8.1 | 7.3 | |
| Debt to Equity ⓘ | -0.1 | -0.2 | -0.6 | -0.6 | -0.6 | -0.6 | -0.6 | -0.6 | -1.7 | -2 | - | |
| Working Cap Days ⓘ | 316 | 133 | 146 | 130 | 75 | 60 | 70 | 40 | 38 | 53 | 0 | |
| Cash Conv. Cycle ⓘ | -17 | -73 | -193 | -258 | -290 | -321 | -433 | -212 | -177 | -208 | 0 | |
Sales growth is growing at healthy rate in last 3 years 12.23%
Return on Equity is Poor
Net Profit has been subdued in last 3 years 0.00%
Sales growth is not so good in last 4 quarters at -15.45%
| Standalone | Consolidated | |
|---|---|---|
| TTM EPS (₹) | 0.6 | 1.7 |
| TTM Sales (₹ Cr.) | 7.7 | 10 |
| BVPS (₹.) ⓘ | -2.8 | -4.8 |
| Reserves (₹ Cr.) ⓘ | -13 | -15 |
| P/BV ⓘ | -9.89 | -5.95 |
| PE ⓘ | 48.51 | 16.72 |
| From the Market | |
|---|---|
| 52 Week Low / High (₹) | 17.20 / 31.90 |
| All Time Low / High (₹) | 1.00 / 62.60 |
| Market Cap (₹ Cr.) | 27.3 |
| Equity (₹ Cr.) | 10 |
| Face Value (₹) | 10 |
| Industry PE ⓘ | 68.3 |
| Pledged * | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Medinova diagnostic services was established in the year 1985 as a pioneering concept in Diagnostics. For the first time in the country it offered all the diagnostic services from an ordinary blood test to a sophisticated CT Scan under one roof. With its qualitative services for more than two decades and with innovative marketing efforts, Medinova has created a brand name for itself and is the pioneer in Medical Diagnostics in the Country.
Medinova gives emphasis on providing quality services and is equipped with the latest state of the art diagnostic equipment procured from World renowned suppliers like GE, Marquette, Siemens, Hitachi etc. The quality of the tests done by Centres of Medinova meet international standards.Medinova has upgraded its equipment to make best use of latest technology.
Business area of the company
The Company is engaged in the business of providing comprehensive range of diagnostic services spanning pathological investigations, radiology & imaging, conventional, specialized lab services and diagnostic cardiology.
MoneyWorks4Me rating and ranking of funds for SIP is available to subscribers only. Moneyworks4Me is not a rating and ranking agency, however it is required that users have a way of selecting funds and building a Portfolio. The method used by it are described below to enable users to understand the logic behind the rating and ranking Subscriber will find more details on this in the various content made available from time to time. In case you need more please write to besafe@moneyworks4Me.com
MoneyWorks4Me rates and ranks mutual funds based on the following data-driven system:
Funds ranking in screeners: Performance Consistency and Quality are two parameters used for ranking funds for SIP. The ranking as follows GG, GO, GR, OG, OO, OR, RG, RO and RR.
With the same color-coded funds, the one with the higher Average 3-year rolling returns (over 5 to 10 years), the number that appears in the Performance tag, ranks higher.
Here is the summary:
The third tag Upside Potential is not relevant for SIP. It is relevant for lumpsum investments in Mutual Funds.
Download APP
